NeoGenomics (NEO) Earnings Preview: Analysts Estimate 11.7% Revenue Growth
Earnings Release: Tomorrow
Analysts' Consensus:
* Revenue: $173.8 million (+11.7% YoY)
* Adjusted EPS: $0.03
Key Metrics to Watch:
* Revenue growth compared to the 12.1% increase in Q4 2021
* Profitability margins and expense management
* Updates on commercialization of new products and partnerships
* Business outlook and guidance for 2023
Peer Performance:
* Quest Diagnostics: 14.6% YoY revenue growth, beating expectations
* Labcorp: 9.8% YoY revenue growth, topping estimates
Market Outlook:
* Healthcare providers and services stocks have generally underperformed recently
* NeoGenomics shares are up 2.8% over the past month, trading at $14.57
* Average analyst price target for NeoGenomics is $20.45